Progression of microalbuminuria to proteinuria in type 1 diabetes: Nonlinear relationship with hyperglycemia

Diabetes

Volumn 49, Issue 1, 2000, Pages 94-100

  Warram, James H ^a,b   Scott, Laura J ^a,b   Hanna, Linda S ^a,b   Wantman, Michael ^a,b   Cohen, Shmuel E ^a,b   Laffel, Lori M B ^a,b   Ryan, Louise ^b,c   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTICLE; COLORIMETRY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEPHELOMETRY; PRIORITY JOURNAL; PROTEINURIA; URINARY EXCRETION;

EID: 0033985279     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.1.94     Document Type: Article

References (44)

1. Mogensen CE, Christensen CK, Vittinghus E: The stages of diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy. Diabetes 32 (Suppl. 2):64-78, 1983
2. Viberti G, Keen H: The patterns of proteinuria in diabetes mellitus: relevance to pathogenesis and prevention of diabetic nephropathy. Diabetes 33:686-692, 1984
3. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
4. Diabetes Control and Complications Trial Research Group: The effect of intensified treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Krolewski AS, Laffel L, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
6. Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T: The predictive value of microalbuminuria in IDDM: a five-year follow-up study. Diabetes Care 17:120-125, 1994
7. Rudberg S, Dahlquist G: Determinants of progression of microalbuminuria in adolescents with IDDM. Diabetes Care 19:369-371, 1996
8. Microalbuminuria Captopril Study Group: Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 39:587-593, 1996
9. Gilbert RE, Tsalamandris C, Bach LA, Panagiotopoulos S, O'Brien RC, Allen TJ, Goodall I, Young V, Seeman E, Murray RML, Cooper ME, Jerums G: Long-term glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int 44:85:5-859, 1993
10. Wang PH, Lau J, Chalmers TC: Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341:1306-1309, 1993
11. Microalbuminuria Collaborative Study Group, United Kingdom: Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. BMJ 311:973-977, 1995
12. Diabetes Control and Complications (DCCT) Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47:1703-1720, 1995
13. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7:930-937, 1996
14. Ginsberg JM, Chang BS, Maltarese RA, Garella S: Use of single-voided urine samples to estimate quantitative microalbuminuria. N Engl J Med 309:1543-1546, 1983
15. Nathan D, Rosenbaum C, Protasowiski D: Single void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 10:414-418, 1987
16. Dunn PJ, Jury DR: Random urine albumin:creatinine ratio measurements as a screening test for diabetic microalbuminuria: a five year follow-up. N Z Med J 103:562-564, 1990
17. Watts GF, Kubal C, Chinn S: Long-term variation of urinary albumin excretion in insulin-dependent diabetes mellitus: some practical recommendations for monitoring microalbuminuria. Diabetes Res Clin Pract 9:169-177, 1990
18. Bennett FH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE: Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kid Dis 25:107-112, 1995
19. Zelamnovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 20:516-519, 1997
20. Warram JH, Krolewski AS: Use of the albumin/creatinine ratio in patient care and clinical studies. In The Kidney and Hypertension in Diabetes Mellitus. Mogensen CE, Ed. Boston, MA, Kluwer Academic, 1998, p. 85-96
21. Krolewski AS, Warrant JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785-794, 1985
22. Hebert LA, Bain RP, Vernie D, Cattran D, Whittier FC, Tolchin N, Rohde RD, Lewis EJ: Remission of nephrotic range proteinuria in type 1 diabetes: Collaborative Study Group. Kidney Int 46:1688-1693, 1994
23. Ellis D, Lloyd C, Becker DJ, Forrest KY, Orchard TJ: The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. Am J Kidney Dis 27:809-818, 1996
24. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
25. Rothman KJ: Modern Epidemiology. Boston, MA, Little, Brown, 1986, p. 23-34
26. Cox DR, Oakes D: Analysis of Survival Data. New York, Chapman & Hall, 1984, p. 101-104
27. Hastie TJ, Tibshirani RJ: Generalized Additive Models. London, Chapman & Hall, 1990, p. 9-35
28. Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T: The predictive value of microalbuminuria in IDDM: a five-year follow-up study. Diabetes Care 17:120-125, 1994
29. Bach LA, Gilbert RE, Cooper ME, Tsalamandris C, Jerums G: Prediction of persistent microalbuminuria in patients with diabetes mellitus. J Diabet Complications 7:67-72, 1993
30. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430-1432, 1982
31. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
32. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T: Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26:406-410, 1984
33. Remuzzi A, Viberti G, Ruggenenti P, Battaglia C, Pagni R, Remuzzi G: Glomerular response to hyperglycemia in human diabetic nephropathy. Am J Physiol 259:F545-F552, 1990
34. Walczyk MH, Pulliam J, Bennett WM: Effects of hyperglycemia and mannitol infusion on renal hemodynamics in normal subjects. Am J Med Sci 300:218-224, 1990
35. Jenkins DAS, Cowan P, Collier A, Watson ML, Clarke BF: Blood glucose control determines the renal haemodynamic response to angiotensin converting enzyme inhibition in type 1 diabetes. Diabet Med 7:252-257, 1990
36. Miller JA, Floras JS, Zinman B, Skorecki KL, Loagan AG: Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci 90:189-195, 1996
37. The DCCT Research Group: Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 10:1-19, 1987
38. Mathiesen ER, Hommel E, Giese J, Parving H-H: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81-87, 1991
39. Viberti GC, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbumimiria. JAMA 271:275-279, 1994
40. Laffel LMB, McGill JB, Gans DJ on behalf of the North American Microalbuminuria Study Group: The beneficial effect of angiotensin-converting inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 99:497-504, 1995
41. Mogensen CE, Osterby R, Hansen KW, Damsgaard EM: Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 15:1192-1204, 1992
42. Breyer JA, Bain RP, Evans JK, Nahman NS Jr, Lewis EJ, Cooper M, McGill J, Berl T, the Collaborative Study Group: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651-1658, 1996
43. Alaveral AEG, Thomas SM, Sagriotis A, Viberti GC: Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 12 (Suppl. 2):71-74, 1997
44. Mulec H, Blohme G, Grande B, Bjorck S: The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. Nephrol Dial Transplant 13:651-655, 1998